Edmond de Rothschild Investment Partners announced today that its BioDiscovery 3 portfolio company, GlycoVaxyn AG, a privately held specialist vaccine biopharmaceutical company, has been acquired by GlaxoSmithKline in an all-cash transaction valuing the company at approximately $212M.
The collaboration will leverage Genzyme’s long-standing commitment and scientific leadership in the field of adeno-associated virus (AAV) gene therapy and Voyager’s industry-leading AAV product engine to develop breakthrough therapies for patients suffering from severe CNS disorders.
Health officials say two more infants from a suburban Chicago day care have measles, bringing the total number of confirmed cases in Illinois to 10. Chicago and Cook County health officials said Tuesday that nine of the 10 cases are associated with a KinderCare Learning Center in Palatine.
With rampant diabetes and obesity, Mississippi and West Virginia have struggled with health crises. Yet when it comes to getting children vaccinated, these states don't mess around.
Rite Aid and Envision Pharmaceutical Services have entered into a definitive agreement under which Rite Aid will acquire EnvisionRx, a portfolio company of leading global private investment firm TPG, in a transaction valued at approximately $2 billion, which includes the value of an expected future tax benefit of $275 million.
Zoetis has reported fourth-quarter earnings of $126 million. The Florham Park, New Jersey-based company said it had profit of 25 cents per share. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 40 cents per share.
Patients flooded the prestigious Institute of Medicine with stories of years of misdiagnosis or even being dismissed by skeptical doctors. Tuesday, an IOM panel sought to redefine this long-controversial ailment, setting five main symptoms as simple criteria for doctors to use in making a diagnosis.
Following a less than flattering financial performance in 2014, GlaxoSmithKline is realigning its operating structure with its corporate objectives and cashing in on its assets in the process, as the company seeks to drive up external investments and deliver stronger shareholder returns in the long term, says an analyst with research and consulting firm GlobalData.
Noxilizer provides room temperature nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities.
Repligen Corporation announced today that it has completed an 11,000 square foot expansion of its U.S. manufacturing facility. The expansion includes a dedicated space for the production and assembly of Repligen's Alternating Tangential Flow System, the most recent addition to the company's upstream bioprocessing product portfolio.
Researchers at Harvard found that young women who received the vaccine did not engage in more, and riskier, sex.
President Barack Obama's nominee to serve as U.S. drug "czar" won unanimous approval in the Senate Monday as lawmakers vowed to curb an epidemic that results in more than 40,000 deaths a year from overdoses of prescription painkillers, heroin and other substances.
Health officials say the number of measles cases in the nation is up to 121 so far this year. All but 18 of the cases are tied to an outbreak that started at the Disneyland amusement park in California.
It took 16 years of twists and turns. Over and over, Dr. Nancy Sullivan thought she was close to an Ebola vaccine, only to see the next experiment fail. But it is those failures that Sullivan credits for finally leading her to a vaccine promising enough to test in parts of West Africa ravaged by Ebola.
CVS Health's fourth-quarter earnings climbed more than 4 percent in a performance that matched Wall Street expectations even though the pharmacy chain's decision to quit tobacco sales hurt business at its drugstores.